Hematopoietic stem cell transplantation and cellular therapy.

about

Stop and go: hematopoietic cell transplantation in the era of chimeric antigen receptor T cells and checkpoint inhibitors.Treating hematological malignancies with cell therapy: where are we now?

P2860

Q47855599-E399BF77-BAB7-419F-A1CE-7C4D14025327 Q48640926-6D91FBE3-2CCD-4921-8CA7-9FF6FBAA8B54

P2860

Hematopoietic stem cell transplantation and cellular therapy.

Item

http://www.wikidata.org/entity/Q39216720

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hematopoietic stem cell transplantation and cellular therapy.

@en

Hematopoietic stem cell transplantation and cellular therapy.

@nl

type

Item

label

Hematopoietic stem cell transplantation and cellular therapy.

@en

Hematopoietic stem cell transplantation and cellular therapy.

@nl

prefLabel

Hematopoietic stem cell transplantation and cellular therapy.

@en

Hematopoietic stem cell transplantation and cellular therapy.

@nl

P1476

Hematopoietic stem cell transplantation and cellular therapy.

@en

P2093

H-J Kolb

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion

Marrow transplantation for acute nonlymphoblastic leukemia in first remission

Chimeric antigen receptor T cells for sustained remissions in leukemia

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation.

Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.

Immunotherapy with CTLs restricted by nonself MHC.

Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia.

P304

267-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TAN.13005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28371460

http://www.w3.org/2001/XMLSchema#string

Hematopoietic stem cell transplantation and cellular therapy.

about

P2860

P2860

Hematopoietic stem cell transplantation and cellular therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698